Koninklijke Philips (PHG) Depreciation & Amortization (CF) (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Depreciation & Amortization (CF) of $750.9 million for Q2 2026, up 22.16% year-over-year from $614.7 million in Q2 2025, and up 142.03% quarter-over-quarter from $310.2 million in Q1 2026.
Koninklijke Philips (PHG) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Koninklijke Philips' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $750.9 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 22.16% year-over-year to $750.9 million; the TTM figure through Jun 2026 stood at $3.4 billion (down 1.46% YoY), while the FY2024 annual figure was $1.5 billion, up 9.48% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $750.9 million, up from $310.2 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.6 billion in Q4 2022, with the low at $290.3 million in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $746.8 million (2022), against an average of $847.3 million.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) slumped 44.84% in 2024, then soared 66.4% in 2025.
- Koninklijke Philips' Depreciation & Amortization (CF) stood at $1.6 billion in 2022, then declined by 16.99% to $1.4 billion in 2023, then increased by 9.48% to $1.5 billion in 2024, then declined by 11.84% to $1.3 billion in 2025, then tumbled by 42.66% to $750.9 million in 2026.
- Business Quant data shows PHG's Depreciation & Amortization (CF) at $750.9 million in Q2 2026, $310.2 million in Q1 2026, and $1.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 750.89 Mn |
| Jun 30, 2026 | 750.89 Mn |
| Mar 31, 2026 | 310.25 Mn |
| Mar 31, 2026 | 310.25 Mn |
| Dec 31, 2025 | 1.31 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Sep 30, 2025 | 989.02 Mn |
| Sep 30, 2025 | 989.02 Mn |
| Jun 30, 2025 | 614.65 Mn |
| Jun 30, 2025 | 614.65 Mn |
| Mar 31, 2025 | 290.32 Mn |
| Mar 31, 2025 | 290.32 Mn |
| Dec 31, 2024 | 1.49 Bn |
| Dec 31, 2024 | 1.49 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 369.37 Mn |
| Jun 30, 2024 | 369.37 Mn |
| Mar 31, 2024 | 320.48 Mn |
| Mar 31, 2024 | 320.48 Mn |